MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells

Endocrine-Related Cancer

Volumn 18, Issue 6, 2011, Pages 711-719

  Brest, Patrick ^a,b   Lassalle, Sandra ^a,b,c   Hofman, Veronique ^a,b,c   Bordone, Olivier ^c   Tanga, Virginie Gavric ^c   Bonnetaud, Christelle ^c   Moreilhon, Chimene ^b,c,d   Rios, Geraldine ^b,d   Santini, José ^b,c,e   Barbry, Pascal ^b,d   Svanborg, Catharina ^f   Mograbi, Baharia ^a,b   Mari, Bernard ^b,d   Hofman, Paul ^a,b,c  

^a INSERM   (France)

^b UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^c PASTEUR HOSPITAL   (France)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e CENTRE ANTOINE LACASSAGNE   (France)

^f LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; ETOPOSIDE; MICRORNA; MICRORNA 129 5P; STAUROSPORINE; TRICHOSTATIN A; UNCLASSIFIED DRUG; VORINOSTAT;

ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; RNA ISOLATION; THYROID CANCER; THYROID PAPILLARY CARCINOMA;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; LACTALBUMIN; MICROARRAY ANALYSIS; MICRORNAS; OLEIC ACIDS; PRIMARY CELL CULTURE; THYROID NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84855960713     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-10-0257     Document Type: Article

References (31)

1. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F & Garcia-Foncillas J 2009 Epigenetic regulation of microRNA expression in colorectal cancer. International Journal of Cancer 125 2737-2743. (doi:10.1002/ijc.24638)
2. Bolden JE, Peart MJ & Johnstone RW 2006 Anticancer activities of histone deacetylase inhibitors. Nature Reviews. Drug Discovery 5 769-784. (doi:10.1038/nrd2133)
3. Brest P, Gustafsson M, Mossberg AK, Gustafsson L, Duringer C, Hamiche A & Svanborg C 2007 Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. Nature Reviews. Drug Discovery 67 11327-11334. (doi:10.1158/0008-5472.CAN-07-1153)
4. Calin GA & Croce CM 2006a MicroRNA signatures in human cancers. Nature Reviews. Cancer 6 857-866. (doi:10.1038/nrc1997)
5. Calin GA & Croce CM 2006b MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25 6202-6210. (doi:10.1038/sj.onc.1209910)
6. Catalano MG, Fortunati N, Pugliese M, Costantino L, Poli R, Bosco O & Boccuzzi G 2005 Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. Journal of Clinical Endocrinology and Metabolism 90 1383-1389. (doi:10.1210/jc.2004-1355)
7. Catalano MG, Fortunati N, Pugliese M, Poli R, Bosco O, Mastrocola R, Aragno M & Boccuzzi G 2006 Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. Journal of Endocrinology 191 465-472. (doi:10.1677/joe.1.06970)
8. Dowdy SC, Jiang S, Zhou XC, Hou X, Jin F, Podratz KC & Jiang SW 2006 Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. Molecular Cancer Therapeutics 5 2767-2776. (doi:10.1158/1535-7163.MCT-06- 0209)
9. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K et al. 2009 Genomic profiling of microRNAs in bladder cancer: miR-129 is associatedwith poor outcome and promotes cell death in vitro. Cancer Research 69 4851-4860. (doi:10.1158/0008- 5472.CAN-08-4043)
10. Esquela-Kerscher A & Slack FJ 2006 Oncomirs - micro- RNAs with a role in cancer. Nature Reviews. Cancer 6 259-269. (doi:10.1038/nrc1840)
11. Fabien N, Fusco A, Santoro M, Barbier Y, Dubois PM & Paulin C 1994 Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers. Cancer 73 2206-2212. (doi:10.1002/1097- 0142(19940415)73:8〈2206::AID-CNCR2820730828〉3.0.CO;2-M)
12. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al. 2004 Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5 R80. (doi:10.1186/gb-2004-5-10-r80)
13. Gioanni J, Zanghellini E, Mazeau C, Zhang D, Courdi A, Farges M, Lambert JC, Duplay H & Schneider M 1991 Characterization of a human cell line from an anaplastic carcinoma of the thyroid gland. Bulletin du Cancer 78 1053-1062.
14. Greenberg VL, Williams JM, Cogswell JP, Mendenhall M & Zimmer SG 2001 Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. Thyroid 11 315-325. (doi:10.1089/10507250152039046)
15. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70. (doi:10.1016/S0092-8674(00)81683-9)
16. Huber W, von Heydebreck A, Sultmann H, Poustka A & Vingron M 2002 Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1) S96-S104. (doi:10.1093/bioinformatics/18.suppl-1.S96)
17. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N & Akiyama M 1993 In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Research 53 2940-2943. (Pubitemid 23210290)
18. Jones PA & Baylin SB 2007 The epigenomics of cancer. Cell 128 683-692. (doi:10.1016/j.cell.2007.01.029)
19. Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, Amiot F, Magnone V, Bole-Feysot C, Rostagno P, Virolle V et al. 2006 An open-access long oligonucleotide microarray resource for analysis of the human andmouse transcriptomes. Nucleic Acids Research 34 e87. (doi:10.1093/nar/gkl485)
20. Marchion DC, Bicaku E, Daud AI, Richon V, Sullivan DM & Munster PN 2004 Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid. Journal of Cellular Biochemistry 92 223-237. (doi:10.1002/jcb.20045)
21. Mitsiades CS, Poulaki V, McMullan C, Negri J, Fanourakis G, Goudopoulou A, Richon VM, Marks PA & Mitsiades N 2005 Novel histone deacetylase inhibitors in the treatment of thyroid cancer. Clinical Cancer Research 11 3958-3965. (doi:10.1158/1078-0432.CCR-03-0776)
22. Noguchi H, Yamashita H, Murakami T, Hirai K, Noguchi Y, Maruta J, Yokoi T & Noguchi S 2009 Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery. Endocrine Journal 56 245-249. (doi:10.1507/endocrj.K08E-016)
23. Pottier N, Maurin T, Chevalier B, Puissegur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G et al. 2009 Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS ONE 4 e6718. (doi:10.1371/journal.pone.0006718)
24. Prince HM, Bishton MJ & Harrison SJ 2009 Clinical studies of histone deacetylase inhibitors. Clinical Cancer Research 15 3958-3969. (doi:10.1158/1078-0432.CCR-08-2785)
25. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A & Smyth GK 2007 A comparison of background correction methods for two-colour microarrays. Bioinformatics 23 2700-2707. (doi:10.1093/bioinformatics/btm412)
26. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y & Bonner WM 2000 Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. Journal of Biological Chemistry 275 9390-9395. (doi:10.1074/jbc.275.13.9390)
27. Scott GK, Mattie MD, Berger CE, Benz SC & Benz CC 2006 Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Research 66 1277-1281. (doi:10.1158/0008-5472.CAN-05-3632)
28. Strait KA, Warnick CT, Ford CD, Dabbas B, Hammond EH & Ilstrup SJ 2005 Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad. Molecular Cancer Therapeutics 4 603-611. (doi:10.1158/1535-7163.MCT-04-0107)
29. Svensson M, Hakansson A, Mossberg AK, Linse S & Svanborg C 2000 Conversion of alpha-lactalbumin to a protein inducing apoptosis. PNAS 97 4221-4226. (doi:10.1073/pnas.97.8.4221)
30. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V et al. 2007 Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315 1579-1582. (doi:10.1126/science.1136319)
31. Wettenhall JM& Smyth GK 2004 limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20 3705-3706. (doi:10.1093/bioinformatics/bth449)